A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
Clinical trial NCT06384131 · COMPLETED
Trial details
- NCT number
- NCT06384131
- Sponsor
- Assembly Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2025-04-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.